Literature DB >> 28862204

Epidemiological profile of head and neck cancer patients in Western Uttar Pradesh and analysis of distributions of risk factors in relation to site of tumor.

Mohammad Shadab Alam1, Shahid Ali Siddiqui1, Roshan Perween2.   

Abstract

BACKGROUND: Head and neck cancers (HNCs) are a major form of cancers in India. The spectrum varies from place to place within the country because of significant diversified risk factors. AIMS AND
OBJECTIVE: To study, epidemiology and risk factors of HNC patients from Western Uttar Pradesh and to find out the correlation between risk factors and different anatomical regions involved.
MATERIALS AND METHODS: All patients with histologically confirmed diagnoses of HNC between January 2011 and December 2013 were selected from hospital records. Data regarding age, gender, addiction habits, site of tumor, and other details were obtained from their clinical records, and statistical analysis was done. RESULTS AND
CONCLUSION: HNC accounts for 21.2% of total body malignancy and 47% of all malignancies in males and 2.5% in females. Squamous cell carcinoma was the most common histological type (97%). Maximum incidence of HNC (>60%) was in 40-60 year of age. Male:female ratio was 16:1. Oral cancers were most common HNC in patients below 40 year age group, whereas carcinoma oropharynx and larynx were more common in patients above 40 year age group. Tobacco smoking was a most prevalent risk factor for carcinoma oropharynx, larynx, and hypopharynx. Tobacco chewing was a most prevalent risk factor in females, young males, and carcinoma buccal mucosa patients. Habit of tobacco consumption in HNC patients was much higher than their normal counterpart. Alcohols drinking alone was observed in <1% patient as a risk factor. In oral tongue cancer, smoking and tobacco chewing were equally prevalent. Habit of tobacco chewing and alcohol were significantly higher in carcinoma buccal mucosa than other HNC suggesting synergistic effect specific to this site.

Entities:  

Mesh:

Year:  2017        PMID: 28862204     DOI: 10.4103/0973-1482.180687

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  7 in total

1.  Quality of life among head and neck cancer treated patients in South India: A cross-sectional study.

Authors:  Manali Deb Barma; Meignana Arumugham Indiran; Pradeep Kumar R; Arthi Balasubramaniam; M P Santhosh Kumar
Journal:  J Oral Biol Craniofac Res       Date:  2021-02-09

2.  Burden of acute toxicities in head-and-neck radiation therapy: A single-institutional experience.

Authors:  Sandeep Muzumder; Nirmala Srikantia; Avinash H Udayashankar; Prashanth Bhat Kainthaje; M G John Sebastian
Journal:  South Asian J Cancer       Date:  2019 Apr-Jun

3.  The incidence of myocardial infarction and stroke in head and neck cancer patients.

Authors:  Hyun-Keun Kwon; Kyung-Do Han; Yong-Il Cheon; Sung-Chan Shin; Minhyung Lee; Eui-Suk Sung; Jin-Choon Lee; Byung-Joo Lee
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

4.  Body image distress among cancer patients: needs for psychosocial intervention development.

Authors:  Ruchika Rani; Rajesh Kumar
Journal:  Support Care Cancer       Date:  2022-04-12       Impact factor: 3.603

Review 5.  Pepsin and Laryngeal and Hypopharyngeal Carcinomas.

Authors:  Cheng-Yi Yin; Sha-Sha Zhang; Jiang-Tao Zhong; Shui-Hong Zhou
Journal:  Clin Exp Otorhinolaryngol       Date:  2020-07-24       Impact factor: 3.372

6.  Prognostic role of the prognostic nutritional index (PNI) in patients with head and neck neoplasms undergoing radiotherapy: A meta-analysis.

Authors:  Yujie Shi; Yue Zhang; Yaling Niu; Yingjie Chen; Changgui Kou
Journal:  PLoS One       Date:  2021-09-14       Impact factor: 3.240

Review 7.  High-Risk Human Papillomavirus and Epstein-Barr Virus Coinfection: A Potential Role in Head and Neck Carcinogenesis.

Authors:  Rancés Blanco; Diego Carrillo-Beltrán; Alejandro H Corvalán; Francisco Aguayo
Journal:  Biology (Basel)       Date:  2021-11-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.